Stay updated on CB-839 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CB-839 in Solid Tumors Clinical Trial page.

Latest updates to the CB-839 in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded revision tag v3.4.2 and removed the older government funding operating-status notice (Revision: v3.4.1); these changes do not alter the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check23 days agoChange DetectedA site-wide notice warns that information may not be up to date and transactions may not be processed due to a lapse in government funding, with guidance to cc.nih.gov and opm.gov for status. The page shows a revision to version v3.4.1, indicating an updated release of the content.SummaryDifference0.4%

- Check30 days agoChange DetectedA glossary toggle was added to the page, and metadata labels were updated for capitalization (e.g., Last Update Submitted that Met QC Criteria and No FEAR Act Data). The page now displays the revision line Revision: v3.4.0.SummaryDifference0.2%

- Check44 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page; no content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedLocations section was updated with a new Locations header and added state entries (California, Florida, Georgia, Maryland, Massachusetts, New York, Pennsylvania, Tennessee, Texas), while state-specific entries were removed, and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check94 days agoChange DetectedRevision: v3.3.2 was added to the page and Revision: v3.2.0 was removed.SummaryDifference0.0%

Stay in the know with updates to CB-839 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CB-839 in Solid Tumors Clinical Trial page.